-
Phase 1
-
-
18-60Age Range
-
30Locations
-
Recruiting
Recruiting
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple Sclerosis (RMS), Progressive Forms of Multiple Sclerosis (PMS) or Refractory Myasthenia Gravis (MG).
Experimental: Administration of CC-97540 (MG arm)
Experimental: Administration of CC-97540 (PMS arm)
Experimental: Administration of CC-97540 (RMS arm)